NovoCure OverviewNovoCure EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NVCR.
Quarterly EBIT
-$67.42M
↓ 78.05% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$183.92M
↓ 56.94% YoY
Trailing 12 months ending Mar 31, 2026
NovoCure OverviewEBIT (Earnings Before Interest and Taxes) analysis for NVCR.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026